|
HY-D1683-10mg
|
MedChemexpress LLC
|
NBD-PE [CAS 178119-00-1]
|
|
|
|
|
HY-D1683-5mg
|
MedChemexpress LLC
|
NBD-PE [CAS 178119-00-1]
|
|
|
|
|
HY-P76550-10ug
|
MedChemexpress LLC
|
PLK1, Human (sf9, His)
|
|
|
|
|
HY-P76550-5ug
|
MedChemexpress LLC
|
PLK1, Human (sf9, His)
|
|
|
|
|
HY-P76550-50ug
|
MedChemexpress LLC
|
PLK1, Human (sf9, His)
|
|
|
|
|
HY-W010832-100mg
|
MedChemexpress LLC
|
Uridine-5'-diphosphate disodium salt [CAS 27821-45-0]
|
|
COVID-19-anti-virus
|
|
|
HY-W010832-1mL
|
MedChemexpress LLC
|
Uridine-5'-diphosphate disodium salt [CAS 27821-45-0] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-W001160-500mg
|
MedChemexpress LLC
|
5-Hydroxyindole [CAS 1953-54-4]
|
|
|
|
|
HY-W001160-1mL
|
MedChemexpress LLC
|
5-Hydroxyindole [CAS 1953-54-4] (10mM in DMSO)
|
|
|
|
|
HY-P75521-1mg
|
MedChemexpress LLC
|
AKR1B1, Human (His)
|
|
|
|
|
HY-P75521-10ug
|
MedChemexpress LLC
|
AKR1B1, Human (His)
|
|
|
|
|
HY-P75521-100ug
|
MedChemexpress LLC
|
AKR1B1, Human (His)
|
|
|
|
|
HY-P75521-5ug
|
MedChemexpress LLC
|
AKR1B1, Human (His)
|
|
|
|
|
HY-P75521-50ug
|
MedChemexpress LLC
|
AKR1B1, Human (His)
|
|
|
|
|
HY-P75521-500ug
|
MedChemexpress LLC
|
AKR1B1, Human (His)
|
|
|
|
|
HY-P700154AF-10ug
|
MedChemexpress LLC
|
Animal-Free TNF-Beta/TNFSF1, Human (His)
|
|
|
|
|
HY-P700154AF-2ug
|
MedChemexpress LLC
|
Animal-Free TNF-Beta/TNFSF1, Human (His)
|
|
|
|
|
HY-P700154AF-50ug
|
MedChemexpress LLC
|
Animal-Free TNF-Beta/TNFSF1, Human (His)
|
|
|
|
|
HY-B1174-100mg
|
MedChemexpress LLC
|
Bekanamycin [CAS 4696-76-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1174-1mL
|
MedChemexpress LLC
|
Bekanamycin [CAS 4696-76-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-17460A-10mg
|
MedChemexpress LLC
|
Garenoxacin (Mesylate hydrate) [CAS 223652-90-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-17460A-100mg
|
MedChemexpress LLC
|
Garenoxacin (Mesylate hydrate) [CAS 223652-90-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-17460A-5mg
|
MedChemexpress LLC
|
Garenoxacin (Mesylate hydrate) [CAS 223652-90-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-17460A-50mg
|
MedChemexpress LLC
|
Garenoxacin (Mesylate hydrate) [CAS 223652-90-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-17460A-1mL
|
MedChemexpress LLC
|
Garenoxacin (Mesylate hydrate) [CAS 223652-90-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
